Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.373849
+0.0112 (3.10%)
Apr 28, 2026, 1:35 PM EDT - Market open
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $13.56 million as of April 28, 2026. Its market cap has decreased by -25.37% in one year.
Market Cap
13.56M
Enterprise Value
14.66M
1-Year Change
-25.37%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $13.56M, a decrease of -89.76%. That is a compound annual growth rate of -80.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 13.16M | -62.54% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 15.51M |
| Hoth Therapeutics | 15.49M |
| IN8bio | 14.77M |
| Soligenix | 14.33M |
| Phio Pharmaceuticals | 13.82M |
| Moleculin Biotech | 13.55M |
| CDT Equity | 13.36M |
| Intensity Therapeutics | 13.34M |